UK grants emergency authorization for AstraZeneca/Oxford vaccine
A COVID-19 vaccine created by AstraZeneca and the University of Oxford has been approved for emergency use in the United Kingdom.
Roll out will begin Jan 4, Health Secretary Matt Hancock said.
The U.K. Department of Health and Social care announced that it has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorize the vaccine for use.
"This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness," the Department of Health and Social care said in a press release.
It is the second vaccine approved for use in the U.K. following the rollout of the Pfizer/BioNTech vaccine.
The National Health Service will prioritize giving the first doses of the newly approved vaccine to those in the most high-risk groups.
The vaccine will be given in two doses, with four to 12 weeks between doses, the U.K.-based pharmaceutical company said.